CT101a / Shanghai Zeke Biotech, Zhejiang University - LARVOL DELTA

NK Cell Therapy for AML (clinicaltrials.gov) - P1 | N=3 | Terminated | Sponsor: Zhejiang University | N=18 ➔ 3 | Trial completion date: Jun 2025 ➔ Apr 2023 | Recruiting ➔ Terminated | Trial primary completion date: Dec 2024 ➔ Aug 2022; A new study is planed to replace the current study due to IP upgrade

Enrollment change • Trial completion date • Trial primary completion date • Trial termination • Acute Myelogenous Leukemia